A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness
Titel:
A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness
Auteur:
Yoshino, Takayuki Hooda, Naushin Younan, Diana Muro, Kei Shitara, Kohei Heinemann, Volker O’neil, Bert Howard Herrero, Fernando Rivera Peeters, Marc Soeda, Junpei Suh, Mina Reichert, Heidi Mezzi, Khalid Fryzek, Jon Chia, Victoria Rehn, Marko Stintzing, Sebastian